Trade Doximity, Inc. - DOCS CFD

Market is not available at the momentMarket information is presented
as of 2026-08-14T19:47:31+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.12
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.021485 %
(-$4.30)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02149%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000738 %
(-$0.15)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.00074%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close26.52
Open25.88
1-Year Change-59.39%
Day's Range24.75 - 25.88

Trade Doximity, Inc. - DOCS

Keep up-to-date with the Doximity share price using Capital.com’s live chart.

Doximity Inc. (DOCS) is an online social networking platform dedicated to medical professionals in the US. Headquartered in San Francisco and described as the ‘professional medical network for clinicians’ or the ‘LinkedIn for doctors’, Doximity’s platform provides users with a range of features designed to improve communication between doctors, patients and other medical practitioners.

Doximity went public in June 2021, listing its shares on the New York Stock Exchange (NYSE) under the ticker symbol DOCS. 

Join Capital.com today to stay on top of the latest changes in the Doximity Inc. (DOCS) stock price.

The platform, which launched in 2010, was co-founded by Nate Gross, Shari Buck and Jeff Tangney, with a vision to make medical communication effortless – helping clinicians to be more productive, thereby enhancing the patient experience. By 2014, 40% of US physicians had become Doximity members. In 2017, membership had grown to 1 million, accounting for more than 70% of registered physicians in the US.

Similar to other social networking platforms, Doximity is packed with features. Alongside a news feed which provides tailored content to users based on their specialisation or interests, Doximity’s comprehensive directory of medical practitioners allows users to search for other users – be it to discuss a patient referral or catch up about their weekend. Other features include a secure faxing tool, as well as Doximity Dialer, giving members the capability to make telephone or video calls with patients, while ensuring the confidentiality of the user’s personal contact details. 

With Capital.com’s comprehensive DOCS share price chart, you can quickly view the company's current and historic share prices.

On 28 May 2021, the company announced its intention to launch an initial public offering (IPO), filing S-1 with the US Securities and Exchange Commission (SEC). The IPO took place on 23 June 2021, with Doximity selling 23.3 million shares priced at $26 a piece. It raised nearly $600m.

On 24 June, the stock started the trading session on the NYSE at $41.17 a share, before rapidly rising to an intraday high of $53.89 a share. The share price closed the trading day at $53, up 31%.

You can trace all the ups and downs of the Doximity stock quote live and go long or short on the company’s shares with contracts for difference (CFDs) using Capital.com’s proprietary trading platform.

Latest shares articles

SMCI stock forecast
SMCI stock forecast: margins above guidance, $60bn orders
Super Micro Computer said fourth-quarter revenue was tracking near the low end of guidance, while gross margins were above prior guidance and new orders exceeded $60bn. Explore third-party SMCI price targets and technical analysis. Past performance is not a reliable indicator of future results.
34 minutes ago
Micron Technology stock forecast
Micron Technology stock forecast: fiscal Q3 results and outlook
Micron Technology is a US semiconductor company specialising in memory and storage products.Explore third-party MU price targets and technical analysis. Past performance is not a reliable indicator of future results.
an hour ago
Football players on the pitch
Top 10 most valuable football clubs in 2026
Explore Forbes’ 2026 football club valuations, 2024/25 revenue figures and the commercial factors behind the world’s 10 most valuable clubs.
07:06, 12 August 2026
GSK logo displayed on the exterior of a modern office building under a blue sky, representing the global pharmaceutical and healthcare company.
GSK share price: Q2 results, Cambridge R&D investment
GSK reported second-quarter 2026 revenue and core operating profit above analyst-compiled consensus, alongside a £1.9bn cost-savings programme and a £400m Cambridge R&D investment. Explore third-party price targets and technicals. Past performance is not a reliable indicator of future results.
09:30, 11 August 2026
Related News
Public TechnologiesEurope
21:05 (UTC), 11 August 2026
Direktur Doximity Timothy S Cabral lepas 7.500 saham senilai $ 293.325
Reuters NewsEurope
12:12 (UTC), 10 August 2026
Quanterix Q2 revenue rises 34% but cuts 2026 outlook
Reuters NewsEurope
11:09 (UTC), 10 August 2026
Monday.com Q2 revenue rises as AI focus grows
Reuters NewsEurope
12:02 (UTC), 7 August 2026
Doximity shares surge after first-quarter revenue beats estimates
Reuters NewsEurope
20:16 (UTC), 6 August 2026
Doximity Q1 revenue beats analyst estimates
Public TechnologiesEurope
20:09 (UTC), 6 August 2026
Doximity raises FY2027 revenue forecast to $671 million-$681 million

User feedback and ratings

2025-07-01
V***** F******* N***** S****

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-06-30
B******

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-06-27
G** G******

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-06-19
d*********

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-06-19
f*********

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-05-29
C*********

Love the TV integration. Makes traders life smooth and comfortable.

2025-05-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-04-29
d******

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-02-06
N***** B***

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

2025-06-29
p*******

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready